| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $570.7M | -17.4% |
| Cost of Revenue | $385.6M | -19.3% |
| Gross Profit | $185.1M | -13.1% |
| R&D Expense | $10.8M | -0.9% |
| SG&A Expense | $170.9M | -1.4% |
| Operating Income | $14.2M | -64.2% |
| Interest Expense | $471K | -57.0% |
| Pre-tax Income | $14.8M | -62.8% |
| Income Tax | $4.9M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $52.2M | -25.4% |
| Accounts Receivable | $138.3M | +5.1% |
| Inventory | $59.8M | +13.3% |
| Current Assets | $269.1M | +0.1% |
| Total Assets | $442.2M | -0.6% |
| Current Liabilities | $148.1M | -0.9% |
| Total Liabilities | $193.1M | -5.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $8.5M | -78.2% |
| Capital Expenditures | $9.6M | -15.0% |
| Investing Cash Flow | -$12.3M | +4.2% |
| Financing Cash Flow | -$17.1M | +36.4% |
| Free Cash Flow | -$1.1M | -103.9% |
| -11.5% |
| Net Income | $9.9M | -70.9% |
| EPS (Basic) | $0.88 | -73.1% |
| EPS (Diluted) | $0.86 | -72.6% |
| Stockholders' Equity |
| $249.1M |
| +3.6% |